Kairav Bakulesh Shah

Kairav Bakulesh Shah

Active Director Director DIN 08581828
DIN 08581828 First appointment Oct 2019 Primary industry Real Estate and Construction
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Past companies 1 historical roles
Total affiliations 7 Since Oct 2019
Shareholding value •••• Premium profile

About Kairav Bakulesh Shah

Data last updated:

Kairav Bakulesh Shah is a Director at Kbs Properties Private Limited (since 2021), Director at Medify Nexus Private Limited (since 2021) and Director at Money Logix Comtrade Private Limited (since 2021), and holds 3 more current directorships. The companies operate in Real Estate and Construction, E-Commerce and Metals and Minerals. The 3 current companies with reported revenue have a combined latest revenue of ₹4.00 Cr; the largest is Kbs Properties Private Limited at ₹3.23 Cr (FY 2025). Earlier, Kairav Bakulesh Shah was a Designated Partner at Medify Nexus Llp (from 2019).

DIN 08581828
Primary Designation Director
Industry Real Estate and Construction
First Appointment 09 Oct 2019
Oldest Company Age 32 yrs
Largest company Kbs Properties Private Limited · ₹3.23 Cr (FY 2025)
Combined revenue ₹4.00 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kbs Properties Private Limited U70100MH1993PTC075609
Director09 Nov 20211993₹3.23 Cr (FY 2025)Active
Medify Nexus Private Limited U72900MH2021PTC357335
Director18 Mar 20212021₹69.6 Lakh (FY 2024)Active
Money Logix Comtrade Private Limited U13203MH1994PTC079753
Director09 Nov 20211994₹7.1 Lakh (FY 2017)Active
Designated Partner02 Sep 20252025Active
Designated Partner22 Jul 20242024Active
Designated Partner17 Jan 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medify Nexus Llp AAQ-7498
Designated Partner09 Oct 20192019Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medify Nexus Llp
Money Logix Comtrade Private Limited
Kbs Properties Private Limited
Medify Nexus Private Limited
Premium access

Shareholding and investment profile for Kairav Bakulesh Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kairav Bakulesh Shah

Kairav Bakulesh Shah currently holds 6 directorships: Kbs Properties Private Limited (Director, since 09 Nov 2021, revenue ₹3.23 Cr (FY 2025)); Medify Nexus Private Limited (Director, since 18 Mar 2021, revenue ₹69.6 Lakh (FY 2024)); Money Logix Comtrade Private Limited (Director, since 09 Nov 2021, revenue ₹7.1 Lakh (FY 2017)); Pro-Vision Builders Llp (Designated Partner, since 02 Sep 2025); Pro-Vision Constructions Llp (Designated Partner, since 22 Jul 2024); and 1 more.

Kairav Bakulesh Shah was first appointed on 09 Oct 2019 as Designated Partner at Medify Nexus Llp. The most recent appointment on record is 02 Sep 2025 at Pro-Vision Builders Llp.

The 3 current companies of Kairav Bakulesh Shah that report revenue have a combined latest revenue of ₹4.00 Cr: Kbs Properties Private Limited ₹3.23 Cr (FY 2025); Medify Nexus Private Limited ₹69.6 Lakh (FY 2024); Money Logix Comtrade Private Limited ₹7.1 Lakh (FY 2017).

Kairav Bakulesh Shah held 1 earlier board appointment: Medify Nexus Llp (Designated Partner, from 09 Oct 2019).

The current boards of Kairav Bakulesh Shah's companies include Bakulesh Trambaklal Shah (Kbs Properties Private Limited), Dattaprasad Sadashiv Koparkar (Kbs Properties Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available